Reinhard Buettner

Title: Reinhard Buettner: Innovator in Melanoma Research

Introduction

Reinhard Buettner is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the area of melanoma treatment. His innovative work has led to the development of a unique patent that addresses critical challenges in cancer therapy.

Latest Patents

Reinhard Buettner holds a patent for a method aimed at inhibiting 'melanoma inhibitory activity' (MIA). This invention focuses on peptides, antibodies, and antibody fragments that inhibit the activity of MIA, which is crucial for advancing melanoma treatment options. His patent represents a significant step forward in the fight against this aggressive form of skin cancer.

Career Highlights

Buettner is associated with Antisense Pharma GmbH, a company dedicated to developing innovative therapies for cancer and other serious diseases. His work at the company has been instrumental in pushing the boundaries of current medical research and treatment methodologies.

Collaborations

Reinhard has collaborated with several talented individuals in his field, including Anja-Katrin Bosserhoff and Mara Szyrach. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in melanoma research.

Conclusion

Reinhard Buettner's contributions to melanoma research through his innovative patent and collaborative efforts highlight his commitment to advancing medical science. His work continues to inspire and pave the way for future developments in cancer treatment.